Medical Health & Life Science Research News

Research details developments in the Oral mucositis treatment pipeline review H2 2017

Medical Market Research

The Oral Mucositis (Gastrointestinal) pipeline guide also reviews of key players involved in therapeutic development for Oral Mucositis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Phase III, Phase II, Phase I and Preclinical stages are 1, 8, 3 and 6 respectively.

Pune, India, 18th August 2017: WiseGuyReports announced addition of new report, titled “Oral Mucositis - Pipeline Review, H2 2017



Oral mucositis Make an Inquiry about this news is the most common type of mucositis. It is a debilitating complication of cancer surgery, chemotherapy and radiation.

Symptoms include change in color, hyposalivation, a change in the integrity of the mucosa and the presence of edema on the lips and/or the tongue. Treatment included oral decontamination (mouth care) and oral debridement.

GET SAMPLE REPORT @…ne-review-h2-2017 Make an Inquiry about this news              

Report Highlights

Pharmaceutical and Healthcare latest pipeline guide Oral Mucositis - Pipeline Review, H2 2017, provides comprehensive information on the therapeutics under development for Oral Mucositis (Gastrointestinal), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

Similarly, the Universities portfolio in Preclinical stages comprises 1 molecules, respectively.

Oral Mucositis (Gastrointestinal) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.


- The pipeline guide provides a snapshot of the global therapeutic landscape of Oral Mucositis (Gastrointestinal).

- The pipeline guide reviews pipeline therapeutics for Oral Mucositis (Gastrointestinal) by companies and universities/research institutes based on information derived from company and industry-specific sources.

- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.

- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.

- The pipeline guide reviews key companies involved in Oral Mucositis (Gastrointestinal) therapeutics and enlists all their major and minor projects.

- The pipeline guide evaluates Oral Mucositis (Gastrointestinal) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.

- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.

- The pipeline guide reviews latest news related to pipeline therapeutics for Oral Mucositis (Gastrointestinal)

Reasons to access

- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.

- Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.

- Find and recognize significant and varied types of therapeutics under development for Oral Mucositis (Gastrointestinal).

- Classify potential new clients or partners in the target demographic.

- Develop tactical initiatives by understanding the focus areas of leading companies.

- Plan mergers and acquisitions meritoriously by identifying key players and it’s most promising pipeline therapeutics.

- Formulate corrective measures for pipeline projects by understanding Oral Mucositis (Gastrointestinal) pipeline depth and focus of Indication therapeutics.

- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.

- Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.

Table of Content: Key Points

Table of Contents 2

List of Tables 3

List of Figures 3

Introduction 5

Oral Mucositis - Overview 6

Oral Mucositis - Therapeutics Development 7

Pipeline Overview 7

Pipeline by Companies 8

Pipeline by Universities/Institutes 10

Products under Development by Companies 11

Products under Development by Universities/Institutes 12

Oral Mucositis - Therapeutics Assessment 13

Assessment by Target 13

Assessment by Mechanism of Action 15

Assessment by Route of Administration 17

Assessment by Molecule Type 19

Oral Mucositis - Companies Involved in Therapeutics Development 21

Clevexel Pharma SAS 21

Colby Pharmaceutical Company 21

Galera Therapeutics Inc 22

Humanetics Corp 22

Innovation Pharmaceuticals Inc 23

Onxeo SA 23

Oragenics Inc 24

Otsuka Holdings Co Ltd 24

Soligenix Inc 25

Spectrum Pharmaceuticals Inc 25

Spherium Biomed SL 26

Oral Mucositis - Drug Profiles 27

AG-013 - Drug Profile 27

BCD-600 - Drug Profile 30

BIO-300 - Drug Profile 31

brilacidin tetrahydrochloride - Drug Profile 34

clonidine hydrochloride ER - Drug Profile 46

CVXL-0095 - Drug Profile 50

dusquetide - Drug Profile 51

EC-18 - Drug Profile 58

GC-4419 - Drug Profile 60

Gene Therapy for Oral Mucositis - Drug Profile 63



ACCESS REPORT @…ne-review-h2-2017 Make an Inquiry about this news            

News From

Wise Guy Reports - Market ResearchWise Guy Reports
Category: Market Research Publishers and RetailersCompany about: Wise Guy Reports understand how essential statistical surveying information is for your organization or association. Therefore, we have associated with the top publishers and research firms all specialized in specific domains, ensuring you will receive the most reliable and up to date research data available. We also provide COTS (Commercial off the Shelf) business sector reports as custom exploration agreeing your particular needs. Our Market Research Reports and Consulting Services  ...
This email address is being protected from spambots. You need JavaScript enabled to view it.

For more information:

Make an Inquiry about this report HERE!